Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients

Journal of Affective Disorders

Volumn 72, Issue 1, 2002, Pages 95-101

  Vallejo, J ^a   Rosel, P ^b   Arranz, B ^c   Urretavizcaya, M ^a   Menchon J M ^a   Contreras, F ^d   Navarro, M A ^b  

^a CSU Bellvitge ^*  (Spain)

^b CSU de Bellvitge   (Spain)

^c Mental Health Center   (Spain)

^d Unidad de Salud Mental   (Spain)

Author keywords

Delusion; Depression; Melancholia; Serotonin reuptake site; 3H Imipramine

Indexed keywords

IMIPRAMINE; TRITIUM;

ADULT; AGED; ARTICLE; BINDING SITE; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSIONAL DISORDER; DEPRESSION; FEMALE; HUMAN; HUMAN CELL; MALE; MELANCHOLIA; MOOD DISORDER; NEUROBIOLOGY; PRIORITY JOURNAL; RATING SCALE; SEROTONIN UPTAKE; THROMBOCYTE;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BINDING SITES; BINDING, COMPETITIVE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DELUSIONS; DEPRESSIVE DISORDER; FEMALE; HUMAN; IMIPRAMINE; MALE; MIDDLE AGE; SEROTONIN;

EID: 0036774005     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(01)00423-2     Document Type: Article

References (28)

1. Abraham K.I., Ieni J.R., Meyerson L.R. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex. Biochim. Biophys. Acta. 923:1987;8-21.
2. Arranz B., San L. Dependencia de alcohol y sistema serotoninérgico: Implicaciones terapeúticas. Med. Clin. (Barc.). 109:1997;599-605.
3. Arranz B., Rosel P., Sarró S., Zaldivar E., Cano R., Navarro M.A., San L. Platelet serotonergic binding sites in alcohol-dependent patients. Alcohol. Alcohol. 34:1999;726-732.
4. 3H]imipramine binding: Comparative data on normal and affectively ill subjects. Neuropsychobiology. 19:1988;9-11.
5. Blier P., Galzin A.M., Langer S. Diurnal variation in the function of serotonin terminals in the rat hypothalamus. J. Neurochem. 52:1989;453-459.
6. Cryan J.F., Leonard B.E. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum. Psychopharmacol. Clin. Exp. 15:2000;113-135.
7. 3H]imipramine binding in rabbit platelets. Arch. Pharmacol. 336:1987;464-466.
8. 3H]Imipramine binding sites in platelets of hospitalized psychiatric patients. Psychiatry Res. 14:1985;177-187.
9. 3H]imipramine binding sites in depressed patients and healthy controls: a comparison between morning and afternoon samples. J. Affect. Disord. 16:1989;65-70.
10. Gross-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci. Biobehav. Rev. 22:1998;653-661.
11. Halbreich V., Rojansky N., Zander K.J., Barkai A. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J. Psychiatr. Res. 25:1991;7-18.
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
13. Hrdina P.D. Imipramine binding sites in brain and platelets: role in affective disorders. Int. J. Clin. Pharmacol. Res. 9:1989;119-122.
14. Joyce J.N., Shane A., Lexow N., Winokur A., Casanova M.F., Kleinman J.E. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenia. Neuropsychopharmacology. 8:1993;315-336.
15. Laruelle M., Toti R., Abi-Dargham A., Casanova M., Toti R., Weinberger D.R., Kleinman J.E. Selective abnormalities of prefrontal serotonergic markers in schizophrenia: a post-mortem study. Arch. Gen. Psychiatry. 50:1993;810-818.
16. Lewis D.A., McChesney C. Tritiated imipramine binding distinguishes among subtypes of depression. Arch. Gen. Psychiatry. 42:1985;485-488.
17. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology. 21:1999;99S-105S.
18. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;203-225.
19. Mellerup E., Langer S.Z. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study. Pharmacopsychiatry. 23:1990;113-117.
20. 3H]imipramine binding, platelet serotonin content, and plasma cortisol in healthy volunteers. Biol. Psychiatry. 26:1989;794-804.
21. 3H]imipramine binding in depressed patients and its circadian variations in healthy controls. J. Affect. Disord. 11:1986;207-212.
22. Pacheco M.A., Jope R.S. Phosphoinositide signaling in human brain. Prog. Neurobiol. 50:1996;255-273.
23. 3H]paroxetine binding in depressed patients. J. Affect. Disord. 44:1997;79-85.
24. 3H]paroxetine binding sites in suicide brains. Psychiatry Res. 82:1998;161-170.
25. 3H]paroxetine binding sites in platelets from depressed patients. J. Affect. Disord. 52:1999;225-233.
26. 3H]imipramine binding and serotonin uptake in the rat brain. J. Neurochem. 52:1989;507-514.
27. Siegel, S., 1956. Nonparametric Statistics for the Behavioural Sciences. International Editions Statistics Series. McGraw-Hill, New York.
28. Wirz-Justice A. Circadian rhythms in mammalian neurotransmitter receptors. Prog. Neurobiol. 29:1987;219-259.